MedTrace Logo

The Effects of L-Tyrosine on 24 Hour Blood Pressure and Heart Rate in Parkinson's Disease

NCT02259049 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2016-01-20

No results posted yet for this study

Summary

The investigators are observing the effects 2,000 mg of L-tyrosine will have on 24 hour blood pressure fluctuations in individuals with Parkinson's disease.

Conditions

  • Blood Pressure

Interventions

DIETARY_SUPPLEMENT

L-tyrosine

Each subject will receive 2,000 mg of L-tyrosine BID for 24 hours.

DIETARY_SUPPLEMENT

Sugar Pill

Each subject will receive a sugar pill BID for 24 hours.

Sponsors & Collaborators

  • New York Institute of Technology

    lead OTHER

Principal Investigators

  • Joanne Donoghue, PhD · New York Institute of Technology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
84 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02259049 on ClinicalTrials.gov